In a framework of steady development nationally and internationally, Sunrise has signed an exclusive distribution contract with Sun Pharma.
Sun Pharma is a leading global generic and specialty pharmaceutical company known for its high quality products and extensive global presence. It is distinguished by its commitment to innovation and promoting access to medicines, providing solutions to improve the health and well-being of patients worldwide.
These characteristics have enabled it to take fourth place on the global generic scale, where it figures alongside other major players such as Teva, Sandoz, and Viatris.
With as many as 40 plants worldwide, Sunpharma offers a very broad portfolio of products in more than 100 countries, with solutions including:
Generic Drugs:
Sun Pharma is a leading manufacturer of generic drugs made following strict testing standards and certified internationally, used in multiple therapeutic areas such as psychiatry, urology, infectious disease, and various other healthcare fields.
Specialty Medicines:
The company also focuses on the development and production of specialty medicines, helping to improve access to treatments for millions of patients in key areas such as oncology, dermatology, diabetes and ophthalmology.
Pesticides:
Sun Pharma has also explored plant-derived products, such as AQCH, for the treatment of diseases such as COVID-19, in collaboration with the prestigious ICGEB in Trieste, Italy.
Thanks to the company’s Italian headquarters, located directly in the heart of Milan, Sunrise is able to optimize distribution in the domestic market, meeting an increasingly widespread need for access to effective and affordable treatments.